Plasma lipid alterations in leukemia and lymphoma

Area of Science:

• Oncology
• Lipid Metabolism
• Hematology

Background:

• Plasma lipid and lipoprotein abnormalities are observed in various cancers.
• The specific lipid profile in acute leukemia and non-Hodgkin's lymphoma requires further elucidation.

Purpose of the Study:

• To investigate plasma lipid and lipoprotein profiles in patients with acute leukemia and non-Hodgkin's lymphoma.
• To correlate lipid alterations with tumor burden and disease status.

Main Methods:

• Plasma lipid and lipoprotein levels were measured in 25 patients at diagnosis.
• Lipid profiles were reassessed in patients who achieved remission.
• Correlation analysis was performed between lipid abnormalities and tumor burden, including bone marrow involvement.

Main Results:

• All patients displayed abnormalities in at least one plasma lipid fraction.
• A consistent pattern of extremely low high-density lipoprotein cholesterol (median [Xm] = 23), elevated triglycerides (Xm = 165), and elevated very-low-density lipoprotein (Xm = 26) was observed.
• Lipid values normalized upon remission, with abnormalities correlating directly with tumor burden, especially bone marrow involvement.

Conclusions:

• Patients with acute leukemia and non-Hodgkin's lymphoma exhibit high incidence of systemic lipid metabolism abnormalities.
• Impaired triglyceride clearance is a potential mechanism underlying these lipid alterations.
• Lipid profile normalization during remission highlights the reversibility of these metabolic disturbances.